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Dietary rapamycin inhibits mTOR, reduces age-related 
pathologies and extends lifespan, but it is unknown if it 
reverses age-related arterial dysfunction. The effects 
of mTOR inhibition on endothelial function and arterial 
stiffness were evaluated in young (Y: 6±2 mo) and old 
(O: 30±2 mo) male B6D2F1 mice fed control (C) or 
rapamycin-supplemented diet (RAP: 14mg/kg 
encapsulated chow) ad libitum for 6 weeks. Aortic 
mTOR signaling, assessed by S6 Kinase (S6K) 
Western blot, was higher in aged mice (P<0.05) and 
lower in rapamycin-treated old mice (P<0.05). 
Rapamycin selectively increased NO bioavailability 
(OC v. ORAP, P<0.05) and augmented endothelium-
dependent dilation (EDD) to acetylcholine (YC: 96±2% 
v. OC: 73± 4%, P<0.05; v. ORAP: 95±1%, P<0.05) in 
carotid arteries of old mice. RAP also reduced aortic 
stiffness, assessed by pulse wave velocity, in old 
animals (Post-Pre: -43±19 cm/s, P<0.05). These 
improvements coincided with lower aortic nitrotryosine 
(YC: 1.0±0.2 v. OC: 4.7 ±1.6, P<0.05; v ORAP: 
1.5±0.3, P<0.05) and collagen expression (YC: 37±9% 
v. OC: 78±5%, P<0.05; v. ORAP: 50±9%, P<0.05). In 
young mice, RAP impaired endothelial function 
(P<0.05) and did not affect arterial stiffness. In 
conclusion, rapamycin improves arterial function in old 
mice with enhanced mTOR activity, suggesting that 
mTOR may be an effective therapeutic target in older 
adults. 
 RESULTS                                            
• Reducing mTOR signaling via six weeks of dietary 
rapamycin supplementation improved endothelial 
function and NO bioavailability by lowering oxidative 
stress in old mice 
• Rapamycin treatment in old mice resulted in blunted 
aortic arterial stiffness and was associated with lower 
collagen content 
• Rapamycin treatment blunted arterial vasoreactivity in 
young mice suggesting that improvements in arterial 




1. Kochanek, K. D., Xu, J., Murphy, S. L., Miniño, A. M., Kung, H. C.  Deaths: Preliminary Data for 2009. Centers for Disease Control 
and Prevention National Vital Statistics Report 59, 5 (16 March 2011). 
2. Lakatta, E. G. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and 
Molecular Clues to Heart and Arterial Aging. Circulation 107, 490-497 (2003). 
3. Eskurza, I., et al.. Effect of acute and chronic ascorbic acid augmentation on flow-mediated dilation with physically active and 
sedentary aging. J Physiol 215-224. (2004). 
4. Donato, A. J. et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-
dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100, 1659-1666 (2007). 
5. Gerhard, M., et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. 
Hypertension 849-853 (1996). 
6. Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-
142 (1991). 
7. Wilkinson, John E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675-682 (2012). 
8. Ramos, FJ., et al. Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C–Deficient Mice, Rescues Cardiac and Skeletal 
Muscle Function, and Extends Survival. Sci Transl Med 144 (25 July 2012).  
9. Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395 (2009). 
10. Reddy, A. K. et al. Measurement of aortic input impedance in mice: effects of age on aortic stiffness. Am J Physiol Heart Circ 
Physiol H1464-1470 (2003). 
11. Lesniewski, L. A. et al. B6D2F1 Mice are a suitable model of oxidative stress-mediated impaired endothelium-dependent dilation 
with aging. J Gerontol A Biol Sci Med Sci 64, 9-20 (2009). 
 
Supported by HL107120, AG000279,  AG029337,  AG040297,  AG033196 and AG033755  
Animal Model 
• Mice were purchased from aged rodent colonies maintained at Charles River 
Inc., and studied at 4-6 mo (young: Y) and 29-31 mo (old: O) of age.  
• Animals were assigned to one of four experimental groups: young control, 
young rapamycin-treated, old control, and old rapamycin-treated.  
• The mice were housed with a 12:12 light-dark cycle, fed standard chow or 
standard chow  supplemented with rapamycin and water ad libitum for six 
weeks (Rapamycin dose at 14 mg/kg of standard chow9).  
• Body weight and food/water consumption were monitored weekly before, 
during, and after 6 weeks of treatment. 
• Non-terminal measures were performed pre- and post-rapamycin. 
 
Vascular Function 
Aortic Pulse Wave Velocity 
• Aortic pulse wave velocity (PWV) was measured on anesthetized mice before 
and after treatments by the use of two Doppler probes, one placed externally 
next to the aortic arch and the other next to the abdominal aorta.   
• Distance between the two probes divided by the time required for a bolus of 
blood to travel from one probe to the other were used to compute the velocity 
of the pulse. Stiffening of the aorta reduces compliance, thus increasing the 
speed of the pulse wave.10 
Endothelium In-/Dependent Dilation 
• Carotid arteries were incubated in warm physiological saline solution at 37°C, 
pressurized to 50 mmHg, and allowed to equilibrate for 60 minutes. Vessels 
were pre-constricted with phenylephrine (2μM).  
• Lumen diameter was measured in response to cumulative addition of 
acetylcholine (ACh: 10-9-10-4 M), in the absence or presence of the nitric oxide 
synthase inhibitor, L-NAME (0.1mM).  
• ACh responses were repeated in the contra-lateral vessel after incubation with 
the superoxide dismutase mimetic, TEMPOL (1mM). 
• Endothelium-independent dilation (EID) was determined in response to 
cumulative addition of sodium nitroprusside (SNP: 10-9-10-4 M). 
 
Oxidative Stress 
• Western blots for nitrotyrosine, a marker of oxidative stress, were performed 
on aortic lysates 
 
Collagen Content 
• Aortic tissue was preserved in OCT compound, then cut into 10µm sections. 
• Histochemistry was performed on aortic sections with picrosirius red, which 
stains for collagen I and collagen III. 
 
Statistics: Differences in dose responses were determined via Repeated Measures 
ANOVA and Mean Arterial Pressure/Pulse Wave Velocity via Student’s T-test. P≤0.05, 
with a Bonferonni correction for multiple comparison, P<0.013.  
 • Advancing age is one of the major risk factors for 
developing cardiovascular disease (CVD) and is 
associated with endothelial dysfunction and arterial 
stiffening in men and women in the absence of 
clinical disease2-6. 
• We have previously demonstrated the mammalian 
target of rapamycin (mTOR) signaling is elevated in 
arteries from old mice and is associated with 
endothelial dysfunction and arterial stiffening  
• Rapamycin given to aged mice slows multiple signs 
of aging and extends lifespan9. 
• Currently, it is unknown if rapamycin treatment and 
mTOR inhibition can reverse vascular aging. 
 
 CONCLUSIONS 
Figure 3: Dietary rapamycin ameliorates age-
associated reductions in endothelium dependent 
dilation (EDD) in old, but blunts EDD in young mice. 
Carotid artery EDD was lower in old (black triangles) 
compared with young (white circles) mice. Rapamycin 
treatment reduced EDD in young (black circles), but 
improved EDD in old (grey squares) mice. Incubation with 
L-NAME, a NOS inhibitor, reduced EDD in all groups and 
after L-NAME, EDD was lower in old rapamycin-treated 
mice compared to old mice. Values are means±SEM. * 
Denotes p<0.05 vs Young, † Denotes p<0.05 vs Old, ‡ Denotes 
p<0.05 vs Y-RAP 
Figure 5: Although blunted in young mice by dietary 
rapamycin, endothelium independent dilation (EID) to 
sodium nitroprusside (SNP) was not altered by aging or 
rapamycin treatment in old mice. Dose response curves 
to the cumulative addition of SNP in carotid arteries from 
young (white circles), old (black triangles), young 
rapamycin (white diamonds) and old rapamycin (grey 
squares) treated mice. Values are means±SEM. * Denotes 
p<0.05 vs young control 
Figure 4: In vitro treatment with the superoxide 
dismutase mimetic, TEMPOL, restores endothelium 
dependent dilation (EDD) in carotid arteries from old 
mice but was without effect on arteries from young or 
old rapamycin treated mice. Maximal vasodilation to 
acetylcholine (ACh) in the absence (black bars) or presence 
(grey bars) of TEMPOL in carotid arteries  from young and 
old control and rapamycin (RAP) treated mice. Values are 
means±SEM.* Denotes p<0.05 vs Young ACh, † Denotes p<0.05 
vs Old ACh 
Figure 2: Arterial Stiffening, analyzed via aortic pulse wave velocity (PWV), 
was reduced after dietary rapamycin treatment in old but not young mice. 
Old mice had a significantly greater PWV than young mice (Old 390 ± 11 vs. Young 
306  ± 10 P<0.05, not shown). PWV decreased in old mice (black bar) after 
rapamycin treatment,  whereas there was no effect of rapamycin on PWV in young  
(white bar) mice. Values are means±SEM.  
* Denotes p<0.05 vs pre-treatment 
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 HYPOTHESIS 
We hypothesize that inhibition of mTOR signaling 
with dietary rapamycin will significantly reverse 
age-associated arterial stiffening and endothelial 
dysfunction. 
Figure 7. Age-associated 
increases in arterial collagen 
content are ameliorated by 
rapamycin treatment. Aortic 
collagen content, assessed by 
picrosirius red staining, in young 
(white bar), old (black bar) and 
old rapamycin (grey bar) treated 
(RAP) B6D2F1 mice. Values are 
means±SEM. * Denotes p< 0.05 
vs. Young, † denotes p<0.05 vs. Old 
Control. 
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Figure 1: mTOR signaling assessed by phosphorylation of S6 Kinase (S6K) is 
increased with advancing age and is reduced by dietary rapamycin. 
Total (black bars) and phosphorylated (white bars) S6k , expressed as a  ratio of total 
to phosphorylated , protein expression  in the aortas of young , old and old rapamycin 
treated (RAP) B6D2F1 mice. Values are means±SEM.  * Denotes p<0.05 vs young control 
Figure 6. Age-associated 
increases in arterial 




abundance, an oxidative 
stress marker, in young 
(white bar), old (black bar) 
and old rapamycin (grey 
bar) treated (RAP) B6D2F1 
mice. Values are 
means±SEM. * Denotes p< 
0.05 vs. Young, † denotes 
p<0.05 vs. Old Control. 
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